嗜肝DNA病毒基因组复制与持续性感染
Hepadnavirus Genome Replication and Persistence.
作者信息
Hu Jianming, Seeger Christoph
机构信息
Department of Microbiology and Immunology, Penn State University College of Medicine, Hershey, Pennsylvania 17033.
Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
出版信息
Cold Spring Harb Perspect Med. 2015 Jul 1;5(7):a021386. doi: 10.1101/cshperspect.a021386.
Abstract
Hallmarks of the hepadnavirus replication cycle are the formation of covalently closed circular DNA (cccDNA) and the reverse transcription of a pregenomic RNA (pgRNA) in core particles leading to synthesis of the relaxed circular DNA (rcDNA) genome. cccDNA, the template for viral RNA transcription, is the basis for the persistence of these viruses in infected hepatocytes. In this review, we summarize the current state of knowledge on the mechanisms of hepadnavirus reverse transcription and the biochemical and structural properties of the viral reverse transcriptase (RT). We highlight important gaps in knowledge regarding cccDNA biosynthesis and stability. In addition, we discuss the impact of current antiviral therapies on viral persistence, particularly on cccDNA.
摘要
嗜肝DNA病毒复制周期的标志是共价闭合环状DNA（cccDNA）的形成以及前基因组RNA（pgRNA）在核心颗粒中的逆转录，从而导致松弛环状DNA（rcDNA）基因组的合成。cccDNA作为病毒RNA转录的模板，是这些病毒在受感染肝细胞中持续存在的基础。在本综述中，我们总结了关于嗜肝DNA病毒逆转录机制以及病毒逆转录酶（RT）的生化和结构特性的当前知识状态。我们强调了关于cccDNA生物合成和稳定性方面的重要知识空白。此外，我们讨论了当前抗病毒疗法对病毒持续存在的影响，特别是对cccDNA的影响。
相似文献
1
Hepadnavirus Genome Replication and Persistence.嗜肝DNA病毒基因组复制与持续性感染
Cold Spring Harb Perspect Med. 2015 Jul 1;5(7):a021386. doi: 10.1101/cshperspect.a021386.
2
Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.前基因组 RNA 启动乙型肝炎病毒复制系统有助于研究共价闭合环状 DNA 合成中抗病毒药物和耐药变异体的作用机制。
J Virol. 2022 Dec 21;96(24):e0115022. doi: 10.1128/jvi.01150-22. Epub 2022 Nov 30.
3
PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.PRMT5 通过对共价闭合环状 DNA 转录的表观遗传抑制和对前基因组 RNA 衣壳形成的干扰来限制乙型肝炎病毒复制。
Hepatology. 2017 Aug;66(2):398-415. doi: 10.1002/hep.29133. Epub 2017 Jun 19.
4
Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis.独特的双重抗病毒机制增强乙型肝炎病毒突变并减少病毒 DNA 合成。
Antiviral Res. 2019 Oct;170:104540. doi: 10.1016/j.antiviral.2019.104540. Epub 2019 Jun 25.
5
The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation.宿主 DNA 连接酶在嗜肝 DNA 病毒共价闭合环状 DNA 形成中的作用。
PLoS Pathog. 2017 Dec 29;13(12):e1006784. doi: 10.1371/journal.ppat.1006784. eCollection 2017 Dec.
6
[Comparative analysis of drug resistant mutations in the reverse transcriptase domain of hepatitis B virus covalently closed circular DNA and the viral relax circle DNA].[乙型肝炎病毒共价闭合环状DNA与病毒松弛环状DNA逆转录酶结构域耐药突变的比较分析]
Zhonghua Gan Zang Bing Za Zhi. 2010 Nov;18(11):818-21. doi: 10.3760/cma.j.issn.1007-3418.2010.11.007.
7
Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.细胞质乙型肝炎病毒去蛋白松弛环状 DNA 末端的特征。
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.00922-20.
8
In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.在体感染乙型肝炎病毒的肝细胞的增殖导致小鼠肝细胞核内共价闭合环状 DNA 的丢失。
Hepatology. 2010 Jul;52(1):16-24. doi: 10.1002/hep.23611.
9
Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.慢性感染患者肝内共价闭合环状乙型肝炎病毒DNA的水平及复制活性
Hepatology. 2006 Sep;44(3):694-702. doi: 10.1002/hep.21299.
10
DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.DNA聚合酶κ是乙型肝炎病毒共价闭合环状DNA形成的关键细胞因子。
PLoS Pathog. 2016 Oct 26;12(10):e1005893. doi: 10.1371/journal.ppat.1005893. eCollection 2016 Oct.
引用本文的文献
1
Epigenetic drugs against human DNA viruses and retroviruses.针对人类DNA病毒和逆转录病毒的表观遗传药物。
Antiviral Res. 2025 Aug;240:106218. doi: 10.1016/j.antiviral.2025.106218. Epub 2025 Jun 23.
2
Human hepatoma HepG2 cells are susceptible to infection by domestic cat hepadnavirus.人肝癌HepG2细胞易受家猫嗜肝DNA病毒感染。
J Vet Diagn Invest. 2025 May 12:10406387251339765. doi: 10.1177/10406387251339765.
3
Hepatitis B Virus Nucleocapsid Assembly.乙型肝炎病毒核衣壳组装
J Mol Biol. 2025 Apr 30:169182. doi: 10.1016/j.jmb.2025.169182.
4
Host 3' flap endonuclease Mus81 plays a critical role in trimming the terminal redundancy of hepatitis B virus relaxed circular DNA during covalently closed circular DNA formation.宿主3' 瓣状核酸内切酶Mus81在共价闭合环状DNA形成过程中修剪乙型肝炎病毒松弛环状DNA的末端冗余方面发挥着关键作用。
PLoS Pathog. 2025 Feb 6;21(2):e1012918. doi: 10.1371/journal.ppat.1012918. eCollection 2025 Feb.
5
From the Cytoplasm into the Nucleus-Hepatitis B Virus Travel and Genome Repair.从细胞质到细胞核——乙型肝炎病毒的传播与基因组修复
Microorganisms. 2025 Jan 14;13(1):157. doi: 10.3390/microorganisms13010157.
6
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers.联合血清替代标志物预测乙型肝炎患者cccDNA动态变化
PLoS Comput Biol. 2025 Jan 9;21(1):e1012615. doi: 10.1371/journal.pcbi.1012615. eCollection 2025 Jan.
7
Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B.靶向乙肝cccDNA水平：实现慢性乙型肝炎完全治愈的关键
Pathogens. 2024 Dec 13;13(12):1100. doi: 10.3390/pathogens13121100.
8
Antiviral Agents: Structural Basis of Action and Rational Design.抗病毒药物：作用的结构基础与合理设计
Subcell Biochem. 2024;105:745-784. doi: 10.1007/978-3-031-65187-8_20.
9
Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV.干扰素清除HBV临床疗效受损的潜在机制。
Virol J. 2024 Dec 4;21(1):314. doi: 10.1186/s12985-024-02589-3.
10
Generation of Replication-Competent Hepatitis B Virus Harboring Tagged Polymerase for Visualization and Quantification of the Infection.携带标记聚合酶的具有复制能力的乙型肝炎病毒的产生，用于感染的可视化和定量分析。
Microbiol Immunol. 2025 Jan;69(1):43-58. doi: 10.1111/1348-0421.13183. Epub 2024 Dec 2.
本文引用的文献
1
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.特异性和非肝毒性降解乙型肝炎病毒cccDNA。
Science. 2014 Mar 14;343(6176):1221-8. doi: 10.1126/science.1243462. Epub 2014 Feb 20.
2
Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidation.乙肝病毒聚合酶的末端蛋白和逆转录酶结构域中的序列有助于RNA结合和衣壳化。
J Viral Hepat. 2014 Dec;21(12):882-93. doi: 10.1111/jvh.12225. Epub 2014 Jan 9.
3
The inhibition of hepatitis B virus by APOBEC cytidine deaminases.APOBEC 胞嘧啶脱氨酶对乙型肝炎病毒的抑制作用。
J Viral Hepat. 2013 Dec;20(12):821-8. doi: 10.1111/jvh.12192.
4
Comparative analysis of hepatitis B virus polymerase sequences required for viral RNA binding, RNA packaging, and protein priming.乙型肝炎病毒聚合酶序列的比较分析，这些序列对于病毒 RNA 结合、RNA 包装和蛋白引发是必需的。
J Virol. 2014 Feb;88(3):1564-72. doi: 10.1128/JVI.02852-13. Epub 2013 Nov 13.
5
Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudine.克来夫定对乙型肝炎病毒逆转录酶蛋白引发和 DNA 合成的非竞争性抑制作用。
Antimicrob Agents Chemother. 2013 Sep;57(9):4181-9. doi: 10.1128/AAC.00599-13. Epub 2013 Jun 17.
6
The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.乙型肝炎病毒核糖核酸酶 H 对人类免疫缺陷病毒核糖核酸酶 H 和整合酶酶的抑制剂敏感。
PLoS Pathog. 2013 Jan;9(1):e1003125. doi: 10.1371/journal.ppat.1003125. Epub 2013 Jan 22.
7
Protein-primed terminal transferase activity of hepatitis B virus polymerase.乙型肝炎病毒聚合酶的蛋白引物末端转移酶活性。
J Virol. 2013 Mar;87(5):2563-76. doi: 10.1128/JVI.02786-12. Epub 2012 Dec 19.
8
Effectiveness of hepatitis B treatment in clinical practice.临床实践中的乙型肝炎治疗效果。
Gastroenterology. 2012 May;142(6):1360-1368.e1. doi: 10.1053/j.gastro.2012.01.044.
9
In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase.人乙型肝炎病毒聚合酶体外 ε RNA 依赖性蛋白引发活性。
J Virol. 2012 May;86(9):5134-50. doi: 10.1128/JVI.07137-11. Epub 2012 Feb 29.
10
Selection of chronic hepatitis B therapy with high barrier to resistance.高耐药屏障慢性乙型肝炎治疗的选择。
Lancet Infect Dis. 2012 Apr;12(4):341-53. doi: 10.1016/S1473-3099(11)70314-0. Epub 2012 Feb 9.
Zotero 插件